Ultra High-Volume Scanners

WHITE PAPERS AND CASE STUDIES

• A Shift Towards Biofluorescent Particle Counters In Manufacturing

  Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.

• Office Of Naval Research Contract Leads To New Chlorine Sensor Technology

  Developed from U.S. Office of Naval Research requirements, this multiparameter chlorine sensor offers extended maintenance-free operation, flow-independence, and automatic compensation for reliable, in-pipe monitoring.

• Simplifying The Transition To Multi-Column Chromatography

  Explore the advantages of multi-column chromatography and how to transfer your process from batch to an intensified system, step-by-step.

• Changing The Clinical Feasibility Game With AI

  AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.

• Pharma Custom Isolator For Sterile Lab Process

  This project showcases Germfree’s capacity to provide cutting-edge, bespoke solutions in pharmaceutical manufacturing, underpinning their dedication to innovation, safety, and quality.

• Streamlining Antibody Capture With Multi-Column Chromatography

  Explore innovative solutions to overcome the limitations of traditional batch chromatography, improving efficiency, reducing costs, and optimizing production for complex biologics like monoclonal antibodies.

• Symmetry Surgical Uses Software To Enhance Quality

  Symmetry Surgical enhances operations and quality management using software to improve efficiency, compliance, and data-driven decisions while producing over 2 million surgical devices annually.

• Improving Methodologies For iPSC Manufacturing And Differentiation

  Learn how next-generation workflows are being developed to streamline iPSC manufacturing, enhance differentiation strategies, and overcome the hurdles of scalability and consistency.

• Writing An IND Module 3 For Cell And Gene Therapy Products

  This whitepaper outlines the critical considerations for CGT Investigational New Drug (IND) Module 3, as well as how to avoid clinical holds and ensure regulatory readiness.

• UV Treatment Upgrades In Wales

  In order to improve the treatment performance (because of the continued cost to maintain compliance), and ensure that it would eventually have the treatment capacity to meet future population growth equivalent of up to 225,000, Swansea WwTW was in need of an equipment upgrade.

• How To Unlock The Secret To Repeatable, Scalable Low Turnover

  Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.

• Pharmacokinetic Study Of Salbutamol Through Nose Only Exposure In CD-1 Male Mice

  Explore how using advanced tools like the inExpose system can provide precise measurements of lung and plasma drug concentrations to optimize inhalation therapy for pulmonary treatments.